ArticleESMO gastrointestinal oncology2024

High prevalence of NTRK fusions in sporadic dMMR/MSI mCRC RAS/RAF wild-type: an opportunity for a post-immune checkpoint inhibitors progression rescue strategy.

M Svrcek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.